Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

RNA-seq analysis of pulmonary fibrosis induced by alveolar epithelial mitochondrial ND1 deficiency in rats

ABSTRACT: Mitochondrial dysfunction in alveolar epithelial cells has been implicated in the pathogenesis of idiopathic pulmonary fibrosis (IPF), yet direct in vivo evidence remains limited. In this study, we generated a novel rat model with lung epithelium-specific knockout of the mitochondrial ND1 gene by crossing Sftpc-Cre rats with LSL-DdCBE-ND1 rats. The resulting ND1Sftpc-cre rats spontaneously developed pulmonary fibrosis with restrictive ventilatory defects, metabolic abnormalities, and characteristic histopathological changes including alveolar septal thickening, inflammatory infiltration, and collagen deposition. To investigate the molecular mechanisms underlying this phenotype, we performed bulk RNA sequencing on lung tissues from ND1Sftpc-crerats and ND1LSL littermate controls. Differential expression analysis identified genes significantly altered in ND1-deficient lungs. Gene Ontology and KEGG pathway enrichment analyses revealed significant upregulation of extracellular matrix (ECM) organization, p53 signaling pathway, and cell cycle-related processes. This dataset provides transcriptomic insights into the molecular changes associated with epithelial mitochondrial dysfunction-induced pulmonary fibrosis and identifies potential therapeutic targets for interstitial lung diseases.

ORGANISM(S): Rattus norvegicus

PROVIDER: GSE317307 | GEO | 2026/07/20

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

RNA-seq analysis of pulmonary fibrosis induced by alveolar epithelial mitochondrial ND1 deficiency in rats

Project description:RNA-seq analysis of pulmonary fibrosis induced by alveolar epithelial mitochondrial ND1 deficiency in rats

| PRJNA1406715 | ENA

Single cell RNA-sequencing of Lepr+ cells in normal and fibrotic mouse lungs

Project description:A hallmark of pulmonary fibrosis is aberrant activation of lung fibroblasts to become pathological fibroblasts producing excessive extracellular matrix (ECM). Here, we showed Lepr-Cre lineage labels multiple cells types including the majority of alveolar fibroblasts, which signigicatly contribute to pathological fibroblasts in bleomycin induced lung fibrosis.

2024-11-25 | GSE229523 | GEO

Alteration in the transcriptome of the lung during TGF?-induced pulmonary fibrosis

Project description:Pulmonary fibrosis (PF) is associated with many chronic lung diseases including Systemic sclerosis (SSc), Idiopathic Pulmonary Fibrosis (IPF) and Cystic Fibrosis (CF) which are characterized by the progressive accumulation of stromal cells and formation of scar tissue. Pulmonary fibrosis is a dysregulated response to alveolar injury which causes a progressive decline in lung function and refractory to current pharmacological therapies. Airway and alveolar epithelial cells and stromal cells contribute to pulmonary fibrosis but the cell-specific pathways and gene networks that are responsible for the pathophysiology are unknown. Recent animals models generated in our lab demonstrate clinical phenotypes seen in human fibrotic disease. The mouse model of transforming growth factor-? (TGF?)-induced fibrosis include conditionally expressing TGF? in the lung epithelium under control of the CCSP promoter driving rtTA expression (CCSP/TGF?). This allow the TGF? is only expressed in airway and alveolar epithelial cells and only when mice fed doxycycline (Dox). Similar to PF in humans, TGF? mice on Dox developed a progressive and extensive adventitial, interstitial and pleural fibrosis with a decline in lung mechanics. Thus, the TGF? transgenic mouse is a powerful model to determine lung cell-specific molecular signatures involved in pulmonary fibrosis. In this study, we sought to determine changes in the transcriptome during TGF?-induced pulmonary fibrosis. Our results showed that several pro-fibrotic genes increased in the lungs of TGF? mice. This study demonstrates that WT1 network gene changes associated with fibrosis and myfibroblast accumulation and thus may serve as a critical regulator fibrotic lung disease. mRNA profiles of CCSP/- and CCSP/TGFalpha mice treated with Dox

2015-03-07 | E-GEOD-66634 | biostudies-arrayexpress

Enhanced mitophagy promotes lung repair and regeneration by restoring epithelial metabolic fitness [AT2s RNA-Seq]

Project description:Alveolar Type II cells (AT2s) are the stem cells in the alveoli, responsible for both alveolar homeostasis and regeneration. Mitochondrial dysfunction has been reported in the AT2 cells from both chronic and acute injury induced alveolar diseases, including idiopathic pulmonary fibrosis (IPF) and viral pneumonia. Here, we demonstrate that genetic depletion of Ubiquitin Specific Peptidase 30 (USP30), a negative regulator of mitophagy, boosts mitophagy and restores mitochondrial function, leading to protection from injury induced AT2 apoptosis and increased AT2 stem cell activity. Both global Usp30 knockout (KO) and AT2-specific Usp30 KO protects the mice from bleomycin induced lung fibrosis and influenza puneumonia. Moreover, pharmaceutical inhibition of USP30 using a small molecule inhibitor effectively alleviates lung fibrosis and influenza pneumonia. Our study underscores a therapeutic potiential of USP30 inhibition for the treatment of injury induced alveolar diseases, offering a promising strategy for treating injury induced diseases

2026-02-26 | GSE317253 | GEO

Enhanced mitophagy promotes lung repair and regeneration by restoring epithelial metabolic fitness [RNA-Seq]

2026-02-26 | GSE317252 | GEO

Enhanced mitophagy promotes lung repair and regeneration by restoring epithelial metabolic fitness

2026-02-26 | GSE301256 | GEO

Bleomycin and methotrexate-induced pulmonary toxicity in human LC-MSMS

Project description:Drug-induced lung injury rarely, but seriously leads to severe lung diseases such as interstitial pneumonia and pulmonary fibrosis. However, the mechanism underlying drug-induced lung injury remains unclear. Anticancer drugs frequently induce pulmonary damage compared to the other categories of the drugs. In this study, the effect of bleomycin and methotrexate, which are representative pulmonary toxic anticancer drugs, on the comprehensive protein expression levels in alveolar epithelial model cell line, A549.

2025-07-25 | PXD053298 | Pride

Alteration in the transcriptome of lung resident fibroblast isolated from fibrotic lungs of IPF upon genetic knockdown of SOX9

Project description:Pulmonary fibrosis (PF) is associated with many chronic lung diseases including Systemic sclerosis (SSc), Idiopathic Pulmonary Fibrosis (IPF) and Cystic Fibrosis (CF) which are characterized by the progressive accumulation of mesenchymal cells and formation of scar tissue. Pulmonary fibrosis is a dysregulated response to alveolar injury which causes a progressive decline in lung function and refractory to current pharmacological therapies. Airway and alveolar epithelial cells and mesenchymal cells contribute to pulmonary fibrosis but the cell-specific pathways and gene networks that are responsible for the pathophysiology are unknown. Our new findings have identified the aberrant activation of Sox9 in lung resident fibroblasts and myofibroblasts in IPF lung biopsies and the mouse model of transforming growth factor-α (TGFα) and bleomycin-induced pulmonary fibrosis. In this study, we sought to determine Sox9-driven gene networks in lung resident fibroblast during pulmonary fibrosis. Our results showed that Sox9 regulates the transcriptional changes that are required for the fibroblast activation including migration, myofibroblast transformation, survival and extracellular matrix deposition during pulmonary fibrosis. In summary, this new study demonstrates that Sox9 is a critical regulator of fibroblast activation in IPF and hence serve as a target for therapeutic intervention.

2021-12-31 | GSE171532 | GEO

Disease modeling of pulmonary fibrosis using human iPS cell-derived alveolar organoids (fibroblasts)

Project description:We developed an in vitro model of pulmonary fibrosis using alveolar organoids, consisting of human induced pluripotent stem cell-derived alveolar epithelial cells and human lung fibroblasts. In this model, fibroblasts were activated by bleomysin (BLM) treatment in an epithelial cell-dependent manner simillar to the pathogenic mechanism of pulmonary fibrosis.

2021-11-19 | GSE172121 | GEO

Disease modeling of pulmonary fibrosis using human iPS cell-derived alveolar organoids (SPC+ cells)

2021-11-19 | GSE172122 | GEO